Capital S Consulting
AI-powered data analysis finds patients through diagnostic signals - not static territory lists
Most pharmaceutical firms already buy the data that should be driving their commercial work, then leave it sitting in a platform their reps never open. So teams target healthcare providers by specialty and geography while patients with lab markers and diagnostic signals stay unidentified. Capital S builds Salesforce CRM systems that put that real-world data to work - lab results, claims patterns, prescribing behavior - so commercial teams find the right patients faster, move from generic outreach to data-driven provider engagement, and improve patient outcomes. It is the pharma piece of our broader life sciences CRM work, whether you are launching a rare disease therapy or scaling an established brand
Rare disease commercialization is a different problem than primary care. The patient population is small and scattered, the diagnostic journey is long, and a single confirmed patient can change the trajectory of a launch. Generic territory targeting misses these patients entirely. We build rare disease CRM on Salesforce that integrates lab and claims signals to surface the providers treating undiagnosed patients, gives medical affairs equal standing with commercial from day one, and stays lean enough for a first commercial team while it scales with the therapy. The goal is simple: find the right patients faster, so treatment starts earlier and outcomes improve. See our rare disease CRM
We connect your CRM to lab data, claims analytics, and real-world evidence platforms for AI-powered patient identification
Global healthcare data and analytics. Claims data, prescription volumes, and healthcare provider intelligence used for territory planning and market sizing
Real-world patient journey analytics. Maps diagnostic patterns across providers to identify patients earlier in their treatment pathway
Lab data analytics platform. Processes diagnostic test results to identify patients with specific conditions before clinical diagnosis
Now part of PurpleLab. Prescription and medical claims analytics. Tracks therapy adoption patterns and competitive prescribing behavior across territories
These feeds run through an AWS data warehouse that serves as the integration layer between your vendors and Salesforce. We build the ETL pipelines that ingest each feed on a scheduled cadence, validate it against prior loads to catch anomalies, then normalize and transform it before it loads into the CRM. The result is one harmonized source your commercial and medical teams can trust, with data-quality monitoring across every active feed.
Pharmaceutical companies waste resources when sales representatives target healthcare providers based on specialty and practice size instead of actual patient populations. Territory managers work through static lists while patients with diagnostic markers remain unidentified in lab and claims data. Capital S builds pharmaceutical CRM systems that process real-world data to tell field teams which healthcare professionals are treating patients who need their therapy
Process lab data and claims signals to identify patients before symptoms worsen. AI learns which diagnostic patterns predict patient needs, creating qualified leads for sales representatives instead of static territory lists. Where firms move beyond provider-level targeting, we score de-identified patients from lab and claims data and present that patient pipeline alongside the HCP pipeline, with identified data kept in the CRM and de-identified data in the warehouse. See how we built a predictive lead scoring system for a specialty pharmaceutical company
Assign territories dynamically based on where patient signals appear, not arbitrary geography. Balance workload across field teams while ensuring every qualified healthcare professional receives appropriate attention
Centralize every healthcare provider interaction - detailing visits, call notes, and email communications. Sales force automation captures activity in real time, giving managers visibility into customer engagement patterns and rep performance without manual reporting. Field reps spend less time on data entry
Track prescription trends, market share by territory, and conversion rates from patient identification to therapy start. Data analytics show which field representatives are most effective and which healthcare providers respond to specific messaging, enabling smarter resource allocation
Identifying the right patient is only half the job. If the rep walks in without knowing the coverage landscape, the conversation stalls at access. We model the payer environment inside Salesforce so field teams address formulary and prior-authorization barriers proactively rather than discovering them after a script is written
Model the payer landscape that matters to your therapy, including commercial plans, Medicare, and Medicaid, so field teams see which payers hold sway with a given provider and institution
Surface the dominant payer mix within a provider's patient population, giving representatives immediate context on the coverage environment when they plan a call
Capture formulary tier and prior-authorization requirements by payer in structured fields, so reps address access barriers in the conversation instead of leaving them to chance
Ingest payer coverage and formulary data and claims-based payer status through the data warehouse, then map it to the payer objects in Salesforce so the access picture stays current rather than living in static files
Medical affairs teams coordinate key opinion leaders, manage scientific content, and respond to medical inquiries while maintaining strict separation from commercial operations. When these activities scatter across email, spreadsheets, and disconnected systems, pharmaceutical companies lose visibility into KOL relationships and risk compliance violations. Capital S configures CRM software to centralize medical engagement while enforcing role-based & field-based access that keeps medical and commercial data properly separated
Track key opinion leader interactions, research interests, and advisory board participation. Manage relationships across therapeutic areas while maintaining audit trails that prove separation from commercial influence and promotional activity
Route inquiries to appropriate medical science liaisons based on therapeutic expertise and workload. Track response times, scientific content accuracy, and healthcare professional follow-up to ensure consistent medical information delivery
Coordinate congress attendance, publication planning, and scientific presentations. Medical science liaisons access approved content libraries and track which materials resonate with specific healthcare professionals and research institutions
Capture scientific discussions, research collaborations, and investigator-initiated study opportunities in real time. Medical engagement workflows track which key opinion leaders are actively researching relevant therapeutic areas, enabling strategic planning for advisory boards and clinical trial recruitment without commercial team access
Role-based permissions prevent commercial teams from accessing medical content or scientific exchange records. Automated compliance checks flag inappropriate cross-functional requests while audit trails demonstrate proper separation for regulatory inspections. Medical affairs operates independently while sharing unified healthcare provider profiles
Pharmaceutical companies face strict FDA requirements for adverse event reporting, consent management, and audit documentation. When safety signals scatter across email, spreadsheets, and disconnected systems, organizations risk compliance violations and delayed regulatory responses. Pharma CRM systems built on Salesforce centralizes pharmacovigilance workflows, GDPR compliance tracking, and audit trails to ensure pharmaceutical operations meet regulatory requirements without manual coordination
Capture adverse events from healthcare professionals, patients, and sales representatives in real time. Automated workflows route safety signals to pharmacovigilance teams while maintaining regulatory compliance documentation required for FDA submissions and post-market surveillance
Track healthcare provider consent for data processing and communications across all channels. GDPR compliance tools document consent withdrawal requests, data deletion workflows, and privacy management requirements for pharmaceutical industry operations in regulated markets
Every user action generates immutable audit trails showing who accessed what data and when. Document management systems organize regulatory submissions, inspection records, and compliance reports for pharmaceutical companies preparing for FDA audits and regulatory inspections
Pharma companies need CRM software that adapts to their workflows instead of forcing teams into rigid vendor platforms. Capital S configures Salesforce for pharmaceutical industry operations - commercial teams, medical affairs, and regulatory compliance - with AI-powered integrations that identify patients through real-world data. We've helped pharmaceutical companies in rare disease and specialty therapeutics generate measurable ROI through smarter customer relationships
Integrate Prognos, IQVIA, Komodo Health, and Symphony Health directly into your CRM system. AI analytics process lab signals and claims data to identify patients with diagnostic markers, replacing static territory lists with dynamic patient identification workflows
Configure Salesforce to match how your teams actually work instead of forcing processes into predefined vendor templates. Pharmaceutical operations require flexibility as therapeutic areas expand and commercial strategies evolve over time
Support commercial operations, medical affairs, and regulatory compliance in one platform with role-based permissions that maintain proper separation. Unified healthcare provider profiles improve customer engagement across functions without compromising compliance
We understand how rare disease commercialization differs from primary care: smaller patient populations, complex diagnostic journeys, Key Opinion Leader relationships that drive treatment decisions, and medical affairs teams that need equal prominence with commercial operations. Our pharmaceutical industry experience means we configure systems that match these realities
Our implementations deliver tangible results: reduced time from patient identification to therapy start, higher territory efficiency through AI-driven targeting, improved customer engagement across healthcare professionals, and compliance systems that pass regulatory audits. We build CRM software that pharmaceutical companies actually use daily
Building AI Lead Scoring for Early Patient Identification
A rare disease pharmaceutical company partnered with Capital S to solve a critical commercialization challenge: their sales representatives were targeting healthcare providers based on specialty codes and practice size while patients with diagnostic markers remained unidentified in lab data. Traditional pharma CRM approaches meant field teams wasted time on broad disease education instead of patient-specific conversations.
Capital S built an AI lead scoring system that integrated lab and claims data, and prescribing patterns into Salesforce. The system processed diagnostic signals to identify which healthcare professionals were treating patients who needed therapy - before symptoms worsened to the point of specialist referral. Machine learning algorithms learned which combinations of lab results and claims activity predicted patient needs, creating qualified leads for sales reps instead of static territory lists.
"Over three years, the pharmaceutical company identified more than $30 million in incremental revenue opportunities. More importantly, patients received earlier intervention when treatments are most effective. The AI system improved continuously: over half of all patient identifications occurred in the final six months as the platform learned which diagnostic patterns mattered most."
Pharmaceutical companies often prefer Salesforce over Veeva for its flexibility, shorter contract terms, and integration capabilities. While Veeva provides Life Sciences-specific features, its rigid structure forces companies into predefined workflows. Veeva was originally built on Salesforce infrastructure but recently announced plans to migrate to its own technical backend, creating uncertainty about future platform stability and integration capabilities.
Salesforce enables full customization of commercial processes, including territory models, KOL tracking, and compliance workflows. Both platforms charge per-user licensing fees, but Salesforce typically offers shorter contract commitments than Veeva's multi-year requirements. The platform supports broad integrations with market access tools, real-world data platforms, and regulatory systems without vendor lock-in. As commercialization strategies evolve, pharmaceutical companies need Pharma CRM that adapts to new therapies and cross-functional teams rather than forcing workflows into rigid templates.
AI lead scoring identifies patients before definitive diagnostic tests by learning which precursor signals predict disease. In clinical medicine, "smoking gun" tests provide definitive diagnosis for specific conditions. However, patients often show precursor signals in lab data, claims activity, and procedure codes months before these confirmatory tests occur.
Capital S integrates data platforms like Prognos, IQVIA, and Komodo Health into Pharma CRM systems. Machine learning algorithms analyze patterns across thousands of patient journeys to identify which combinations of early indicators most accurately predict eventual diagnosis. The system learns continuously, refining its understanding of which precursor signals matter most.
This enables sales representatives to approach healthcare providers about patients in diagnostic stages rather than waiting for confirmed cases. Traditional territory models target by specialty and practice size, missing patients until symptoms worsen. Pharmaceutical companies using AI lead scoring identify patients 3-6 months earlier, improving treatment outcomes while uncovering revenue opportunities. Read how a rare disease pharmaceutical company used AI lead scoring to identify $30 million in incremental revenue.
Yes. Implementation partners like Capital S build custom integrations using APIs and secure data pipelines that connect pharmaceutical industry data sources directly into CRM software. These integrations enable commercial teams to verify coverage, identify patients through diagnostic signals, and access prescribing intelligence without toggling between systems.
Real-time data flows eliminate manual updates while maintaining HIPAA compliance through tokenization technology that protects patient identity. Healthcare professionals appear as unified profiles enriched with lab signals, claims patterns, and payer intelligence.
Territory managers receive automated alerts when diagnostic markers appear, enabling timely outreach. The pharmaceutical industry increasingly depends on Customer Relationship Management systems that process real-world evidence rather than static lists. Most pharmaceutical companies already purchase market data from vendors like IQVIA, Prognos, or Symphony Health. The key is connecting those sources to actionable workflows.
Sales Cloud is Salesforce's general-purpose CRM. Life Sciences Cloud is the industry product built for pharma, and it ships with much of the data model already configured, including HCP and account management, medical affairs, sample and consent handling, and field engagement, so those foundations are in place rather than built from scratch on a general Sales Cloud org.
We implement Life Sciences Cloud and customize it to how your commercial and medical teams actually work, then extend it with the real-world data integrations, AI lead scoring, and compliance workflows that sit beyond the standard model. You get the head start of the prebuilt data model and the flexibility to shape it around your therapy, rather than choosing between the two.
CRM software tracks pharmaceutical sample inventory, allocation, and healthcare provider signatures in unified systems that ensure regulatory compliance. When sales reps distribute samples, the system captures lot numbers, quantities, and signed attestations required for FDA audits.
Automated compliance checks flag violations before they occur: exceeding sample limits, targeting restricted healthcare providers, or missing required documentation. Pharma companies maintain audit-ready records showing complete sample chain of custody from warehouse to patient.
Integration with inventory management systems updates available sample counts in real time, preventing reps from promising samples they cannot deliver. Territory managers monitor sample effectiveness by correlating distribution with prescription trends and patient starts. The pharmaceutical industry faces strict sample regulations. Customer Relationship Management systems that automate compliance reduce risk while eliminating manual tracking spreadsheets that create audit gaps
Capital S configures role-based permissions and field-level security that make medical content completely invisible to commercial teams while maintaining unified healthcare provider profiles. Medical science liaisons document scientific exchanges, advisory boards, and research collaborations in separate objects that do not appear in commercial user interfaces.
Commercial teams cannot access, view, or even see that medical content exists. The data objects, fields, and records remain entirely hidden from their Salesforce view. Conversely, medical affairs teams cannot see promotional materials, sales targets, or commercial strategy content. Audit trails document which users accessed what data, demonstrating complete separation for regulatory inspections.
This architecture protects pharmaceutical companies from FDA enforcement while enabling cross-functional coordination. Both teams see the same HCP contact information and basic practice details, but medical interactions and commercial activities remain in completely separate data structures. Regulatory compliance requirements demand this separation. Generic CRM software lacks the granular permissions pharmaceutical industry operations require for medical affairs independence.
Pharmaceutical companies need offline CRM capabilities when sales representatives regularly visit healthcare providers in areas with unreliable connectivity: rural practices, hospital basements, or facilities with strict WiFi restrictions. If reps cannot access CRM software during calls, they resort to paper notes and manual data entry later.
Salesforce Life Sciences Cloud provides offline mobile functionality that syncs when connectivity returns. Field representatives access HCP profiles, call plans, and sample inventories without internet. Changes upload automatically once online.
Most pharma companies discover 60-70% of their commercial teams work in areas with adequate connectivity and do not require offline access. Organizations implementing offline capabilities typically do so for specific field-based roles rather than entire commercial organizations. This targeted approach enables offline access for the field roles that need it, while office-based medical affairs and operations teams work online in the same Life Sciences Cloud environment.
Pharmaceutical CRM implementation typically requires 8-12 weeks per functional team. Commercial operations teams (HCP management, activity tracking, sample management) and medical affairs teams are usually implemented sequentially rather than simultaneously. This phased approach ensures smooth adoption as each group masters their workflows before expanding to other functions.
Implementing commercial teams first establishes core CRM infrastructure. Once sales representatives and territory managers are operating effectively, medical affairs implementation adds KOL management, scientific exchange tracking, and MIRF workflows. Regulatory compliance and AI lead scoring capabilities can layer on after foundational systems are stable.
The pharmaceutical industry benefits from sequential rollouts because each team requires different training, workflows, and change management. Pharma companies rushing to implement all functions simultaneously often face adoption challenges as teams compete for attention during onboarding. Staggered timelines allow focused support for each group, increasing long-term CRM software utilization and ROI.
Get a free, no obligation consultation